Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes

Hong-Ki MIN; Boin LEE; Seung-Ki KWOK; Ji-Hyeon JU; Wan-Uk KIM; Young-Min PARK; Sung-Hwan PARK.
The Korean Journal of Internal Medicine ; : 521-530, 2015.
Artículo en Inglés | WPRIM | ID: wpr-58263

Documentos relacionados

  1. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
  2. `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea.
  3. Allopurinol Induced DRESS Syndrome.
  4. Challenges in Diagnosis, Management, and Treatment of Allopurinol-Induced DRESS Syndrome: Case Report and Literature Review.
  5. Allopurinol hypersensitivity syndrome.
  6. <i>HLA-B*58:01</i> Genotyping to Prevent Cases of DRESS and SJS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity [Formula: see text].
  7. Modelling and assessing one- and two-drug dose titrations.
  8. To Treat or Not to Treat? Effect of Urate-Lowering Therapy on Renal Function, Blood Pressure and Safety in Patients with Asymptomatic Hyperuricemia: A Systematic Review and Network Meta-Analysis.
  9. How to prevent allopurinol hypersensitivity reactions?
  10. Serum Urate-Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Trial.